直近一年間の累計
アクセス数 : ?
ダウンロード数 : ?
ID 119205
タイトル別表記
In Vivo Protein Knockdown by SNIPER Compound
著者
Ohoka, Nobumichi National Institute of Health Sciences
奥平, 桂一郎 National Institute of Health Sciences|Tokushima University KAKEN研究者をさがす
Ito, Masahiro Takeda Pharmaceutical Co. Ltd.
Nagai, Katsunori Takeda Pharmaceutical Co. Ltd.
Shibata, Norihito National Institute of Health Sciences
Hattori, Takayuki National Institute of Health Sciences
Ujikawa, Osamu Takeda Pharmaceutical Co. Ltd.
Shimokawa, Kenichiro Takeda Pharmaceutical Co. Ltd.
Sano, Osamu Takeda Pharmaceutical Co. Ltd.
Koyama, Ryokichi Takeda Pharmaceutical Co. Ltd.
Fujita, Hisashi Takeda Pharmaceutical Co. Ltd.
Teratani, Mika Takeda Pharmaceutical Co. Ltd.
Matsumoto, Hirokazu Takeda Pharmaceutical Co. Ltd.
Imaeda, Yasuhiro Takeda Pharmaceutical Co. Ltd.
Nara, Hiroshi Takeda Pharmaceutical Co. Ltd.
Cho, Nobuo Takeda Pharmaceutical Co. Ltd.
Naito, Mikihiko National Institute of Health Sciences
資料タイプ
学術雑誌論文
抄録
Many diseases, especially cancers, result from aberrant or overexpression of pathogenic proteins. Specific inhibitors against these proteins have shown remarkable therapeutic effects, but these are limited mainly to enzymes. An alternative approach that may have utility in drug development relies on selective degradation of pathogenic proteins via small chimeric molecules linking an E3 ubiquitin ligase to the targeted protein for proteasomal degradation. To this end, we recently developed a protein knockdown system based on hybrid small molecule SNIPERs (Specific and Nongenetic IAP-dependent Protein Erasers) that recruit inhibitor of the apoptosis protein (IAP) ubiquitin ligases to specifically degrade targeted proteins. Here, we extend our previous study to show a proof of concept of the SNIPER technology in vivo. By incorporating a high affinity IAP ligand, we developed a novel SNIPER against estrogen receptor α (ERα), SNIPER(ER)-87, that has a potent protein knockdown activity. The SNIPER(ER) reduced ERα levels in tumor xenografts and suppressed the growth of ERα-positive breast tumors in mice. Mechanistically, it preferentially recruits X-linked IAP (XIAP) rather than cellular IAP1, to degrade ERα via the ubiquitin-proteasome pathway. With this IAP ligand, potent SNIPERs against other pathogenic proteins, BCR-ABL, bromodomain-containing protein 4 (BRD4), and phosphodiesterase-4 (PDE4) could also be developed. These results indicate that forced ubiquitylation by SNIPERs is a useful method to achieve efficient protein knockdown with potential therapeutic activities and could also be applied to study the role of ubiquitylation in many cellular processes.
掲載誌名
Journal of Biological Chemistry
ISSN
1083351X
cat書誌ID
AA1202441X
出版者
American Society for Biochemistry and Molecular Biology|Elsevier
292
11
開始ページ
4556
終了ページ
4570
発行日
2017-02-02
権利情報
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
EDB ID
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
薬学系